Sunfox Technologies has raised $7 million, around Rs. 67 crore, in a Series A funding round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital.

The Dehradun-based medtech startup plans to use the money to expand its portable cardiac diagnostics platform, Spandan. Its larger aim is simple but important – bring heart testing closer to patients, especially in places where specialist healthcare is difficult to access.

What Sunfox Technologies does

Sunfox began as a research and development venture in Uttarakhand in 2016. It was founded by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola and Saurabh Badola.

The founders started exploring healthcare technology after losing a friend during their college years. Their work eventually led to Spandan, a portable ECG platform that can connect with a smartphone.

An ECG records the electrical activity of the heart. Doctors use it to study heart rhythm and identify warning signs that may require urgent medical attention.

Spandan is designed for homes, clinics, hospitals, telemedicine networks and public-health centres. A healthcare worker can record a patient’s ECG and share it with a doctor or cardiologist for remote review.

This can be especially useful in rural locations. A patient may not need to travel immediately to a large city for an initial heart assessment. A local health worker can capture the ECG and seek expert guidance from a district hospital or remote-care network.

The purpose of the $7 million funding

The new capital will support Sunfox’s next stage of growth. The company plans to expand its presence across India, hire more employees, strengthen research and development and build international sales and distribution capabilities.

Sunfox is also working toward regulatory clearances in the United States and Europe. Its products already have approvals in India, Ghana, Kenya, Tanzania and South Africa, according to the company’s press release received.

The startup says around 60,000 Spandan devices have been deployed across India and have reached more than 20,000 villages. The platform has been used in clinics, homes and public-health programmes.

Sunfox will also invest in clinical evidence, engineering and new cardiac technologies. These steps are important as the company enters global markets with strict medical-device requirements.

Why Spandan is different

Traditional ECG machines are usually found in hospitals and larger clinics. They can be expensive, bulky and difficult to move. Spandan focuses on portability and smartphone connectivity.

The company’s official product information describes Spandan as a compact ECG system capable of producing digital reports that can be shared with doctors.

Its model combines medical hardware, software and remote doctor support. That combination can help connect frontline health workers with specialists without requiring every patient to visit a major hospital.

However, a portable ECG does not replace emergency care or a qualified doctor. Anyone experiencing severe chest pain, breathing difficulty or other serious symptoms should seek immediate medical attention.

Competition and future plans

Sunfox competes with established ECG manufacturers, telemedicine platforms and remote cardiac-monitoring companies. Its difference lies in combining portable ECG hardware with smartphone-based reporting and remote interpretation.

The company also became widely known after receiving investment from all five investors on the first season of “Shark Tank India”. The latest Series A round could help Sunfox grow from an Indian medtech startup into a global cardiac-care technology company.

Conclusion with key takeaways

Sunfox Technologies has raised $7 million to scale its Spandan portable ECG platform.

The funds will support Indian expansion, international market entry, hiring, research and regulatory approvals.

Spandan aims to make cardiac testing more portable and accessible for homes, clinics and rural healthcare centres.

The company’s biggest opportunity is to reduce delays in initial heart assessment while building a trusted India-made healthcare technology brand.

Indian spacetech startup InspeCity has raised Rs. 100 crore in a pre-Series A funding round, giving a strong push to its plan of building “service stations” for satellites in space.

The round was led by Speciale Invest and investor Ashish Kacholia. Antler Elevate, Antler India, Manish Gandhi, Shastra VC and others also joined the round.

This is an important moment for India’s private space sector because InspeCity is not building rockets or satellites in the usual way. It is working on something more specialized which is that helping satellites live longer, move better, and safely exit orbit when their job is done.

What InspeCity does

InspeCity is building technology for in-space servicing. In simple words, it wants to help satellites after they are already in orbit.

Today, if a satellite runs out of fuel, faces a technical issue, or reaches the end of its life, there are limited options. Many satellites become useless even when some parts are still working. Some also add to the growing problem of space debris.

InspeCity wants to change that with systems that can inspect, approach, dock with, refuel, repair, or safely remove satellites from orbit. Think of it like roadside assistance, but for spacecraft.

Founder and founding year

InspeCity was founded in 2022 by Arindrajit Chowdhury and Tausif Shaikh.

Arindrajit Chowdhury is a professor at IIT Bombay and serves as the founder and CEO of the company. Tausif Shaikh is also linked to IIT Bombay. The startup has been incubated in the IIT Bombay ecosystem and is based in Maharashtra.

Purpose of the Rs. 100 crore funding

The fresh funding will mainly be used to move InspeCity from testing individual technologies to proving them in real space missions.

The company plans to carry out four in-orbit missions over the next 12 to 18 months. These missions will help test important capabilities such as propulsion, sensing, autonomous movement, robotics, docking, and refuelling.

InspeCity is also expected to expand its engineering and manufacturing teams. It will work on commercializing its propulsion systems and other space-service offerings for satellite operators.

Its key platform is called VEDA, short for Vehicle for Life Extension and Deorbiting Activities. The company is also working on systems such as GITA for propulsion, CHAKSU for sensing and navigation, RAMA for robotic work, and SPARSH for docking and fuel transfer.

Why this matters

Satellites are expensive. They support communication, defence, internet, weather tracking, navigation, banking, agriculture, and disaster response. If a satellite can work for a few extra years through servicing or refuelling, the operator can save money and reduce waste in orbit.

There is also a safety angle. Old satellites and broken parts can collide with working satellites. A company that can help remove or manage such objects may become valuable as space becomes more crowded.

Competitors and market space

Globally, companies such as Astroscale, Starfish Space, Orbit Fab, and Northrop Grumman are working on satellite servicing, debris removal, refuelling, and life-extension technologies.

In India, InspeCity is part of a growing spacetech wave that includes companies working on rockets, satellites, propulsion, imaging, and space infrastructure. Its focus on in-orbit servicing makes it different from many startups that are mainly building launch vehicles or satellite platforms.

Conclusion – Key takeaways

InspeCity’s Rs. 100 crore pre-Series A round shows that investors are taking India’s deep-tech space startups more seriously.

The startup’s aim is clear: make satellites more useful after launch and reduce the problem of space debris. The funding will help it run four space missions, strengthen its team, and bring its servicing technology closer to commercial use.

If InspeCity can prove its systems in orbit, it could become an important Indian company in the future space economy.

Facts Input- YS, Entrepreneur, MC